169 related articles for article (PubMed ID: 26117027)
1. [Correlation of WT1 and VEGF Expression with Angiogenesis in Bone Marrow Biopsies of Multiple Myeloma Patients].
Li GJ; Ding H; Yang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):733-6. PubMed ID: 26117027
[TBL] [Abstract][Full Text] [Related]
2. Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma.
Choi JH; Ahn MJ; Jang SJ; Park CK; Park YW; Oh HS; Lee YY; Choi IY; Kim IS
Int J Hematol; 2002 Dec; 76(5):460-4. PubMed ID: 12512841
[TBL] [Abstract][Full Text] [Related]
3. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
5. [Significance of Bone Marrow Microvessel Density and Vascular- Related Factors in Multiple Myeloma].
Xie YB; Fang LF; Jiang BL; Han GX; Shen K; Li WQ; Chen SB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1179-1184. PubMed ID: 31418376
[TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment.
Du W; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T
Pathol Int; 2004 May; 54(5):285-94. PubMed ID: 15086832
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between Expression of CXCL12, CXCR4, VEGF, MVD and Prognosis in Patients with Multiple Myeloma].
Zhang K; Zhou J; Li XM; Huang CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1962-1971. PubMed ID: 33283727
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
[TBL] [Abstract][Full Text] [Related]
9. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor immunoexpression in the context of adverse standard prognostic factors in multiple myeloma.
Ribas C; Colleoni GW; Silva MR; Carregoza MJ; Bordin JO
Eur J Haematol; 2004 Nov; 73(5):311-7. PubMed ID: 15458509
[TBL] [Abstract][Full Text] [Related]
11. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.
Rana C; Sharma S; Agrawal V; Singh U
Ann Hematol; 2010 Aug; 89(8):789-94. PubMed ID: 20177896
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow angiogenesis in aplastic anemia--a study of CD 34 and VEGF expression in bone marrow biopsies.
Gupta P; Khurana N; Singh T; Gupta D; Dhingra KK
Hematology; 2009 Feb; 14(1):16-21. PubMed ID: 19154660
[TBL] [Abstract][Full Text] [Related]
14. [Anti-angiogenesis effect of metronomic chemotherapy in multiple myeloma patients].
Guo LP; Zhou F; Wei W; Zhang YZ; Shi HT; Lin CH; Li L; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):457-60. PubMed ID: 22967380
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment.
Bolkun L; Lemancewicz D; Sobolewski K; Mantur M; Semeniuk J; Kulczynska A; Kloczko J; Dzieciol J
Adv Med Sci; 2013; 58(1):118-25. PubMed ID: 23333895
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in multiple myeloma.
Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
[TBL] [Abstract][Full Text] [Related]
18. [Relevance of tumor angiogenesis in occurrence and development of breast cancer].
Liu Y; Wang G; Xu WG; Song JN; Yang XQ; Wang WY
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1687-9. PubMed ID: 19957527
[TBL] [Abstract][Full Text] [Related]
19. [Bone marrow microvessel density and vascular endothelial growth factor expression in patients with aplastic anemia].
Zhang L; Wang HJ; Li HQ; Yang DL; Yan ZS; Wu YH; Zhou K; Chu YL; Chen HS; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):528-31. PubMed ID: 18078128
[TBL] [Abstract][Full Text] [Related]
20. [Change of vascular endothelial growth factor and its receptors expression in acute myeloid leukemia before and after treatment].
Zhang JQ; Wang JK; Li YM
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):100-2. PubMed ID: 14990052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
